Atria Investments’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Buy
32,981
+2,943
+10% +$210K 0.03% 612
2025
Q4
$1.85M Buy
30,038
+5,716
+24% +$336K 0.02% 757
2025
Q3
$1.43M Buy
24,322
+3,506
+17% +$204K 0.02% 869
2025
Q2
$1.21M Buy
20,816
+5,066
+32% +$286K 0.01% 942
2025
Q1
$782K Buy
15,750
+4,145
+36% +$212K 0.01% 1118
2024
Q4
$519K Sell
11,605
-3,031
-21% -$144K 0.01% 1304
2024
Q3
$703K Buy
14,636
+290
+2% +$14K 0.01% 1157
2024
Q2
$730K Buy
+14,346
New +$785K 0.01% 1104
2023
Q2
Sell
-18,725
Closed -$1.38M 867
2023
Q1
$1.38M Buy
18,725
+3,201
+21% +$247K 0.03% 680
2022
Q4
$1.13M Sell
15,524
-1,433
-8% -$113K 0.02% 717
2022
Q3
$1.41M Buy
16,957
+3,251
+24% +$280K 0.03% 600
2022
Q2
$1.09M Buy
13,706
+1,494
+12% +$145K 0.02% 721
2022
Q1
$1.27M Buy
+12,212
New +$1.01M 0.02% 745
2020
Q1
Sell
-4,416
Closed -$212K 974
2019
Q4
$212K Buy
+4,416
New +$213K 0.01% 1130

Other funds holding NTR

Atria Investments's NTR Position: Q1 2026 in Review

Atria Investments increased its Nutrien (NTR) stake by 9.8% in Q1 2026, buying an estimated $210K and bringing the position to 32,981 shares worth $2.49M. The position accounts for 0.03% of the portfolio, ranked #612.

Atria Investments first reported a position in NTR in Q4 2019 and has held it in 14 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Atria Investments held 32,981 shares of Nutrien worth $2.49M as of Q1 2026.
  • Atria Investments bought 2,943 Nutrien shares in Q1 2026, an estimated $210K.
  • Nutrien made up 0.03% of Atria Investments's portfolio in Q1 2026, its #612 holding.
  • Atria Investments first reported a position in Nutrien in Q4 2019 and has held it in 14 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.